Cite
Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation inalpha2‐macroglobulinandtau: A population‐based autopsy study
MLA
Pentti J. Tienari, et al. “Senile Systemic Amyloidosis Affects 25% of the Very Aged and Associates with Genetic Variation Inalpha2‐macroglobulinandtau: A Population‐based Autopsy Study.” Annals of Medicine, vol. 40, Jan. 2008, pp. 232–39. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e4921de9927d0977299186d6ff0832f1&authtype=sso&custid=ns315887.
APA
Pentti J. Tienari, Liisa Myllykangas, Raimo Sulkava, Irma-Leena Notkola, Andrew B. Singleton, Sari Kiuru-Enari, Terhi Peuralinna, Tuomo Polvikoski, Anders Paetau, Maarit Tanskanen, & John Hardy. (2008). Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation inalpha2‐macroglobulinandtau: A population‐based autopsy study. Annals of Medicine, 40, 232–239.
Chicago
Pentti J. Tienari, Liisa Myllykangas, Raimo Sulkava, Irma-Leena Notkola, Andrew B. Singleton, Sari Kiuru-Enari, Terhi Peuralinna, et al. 2008. “Senile Systemic Amyloidosis Affects 25% of the Very Aged and Associates with Genetic Variation Inalpha2‐macroglobulinandtau: A Population‐based Autopsy Study.” Annals of Medicine 40 (January): 232–39. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e4921de9927d0977299186d6ff0832f1&authtype=sso&custid=ns315887.